insider24.ch
Back to the feed

Shareholding disclosure

Kuros Biosciences AG

inKuros Biosciences AG

Declared position

15.59%

Threshold

Crossed downwards

Timeline

Published

06.10.2017

Transaction

29.09.2017

Voting rights breakdown

Voting rights acquired0.06%
Voting rights sold15.59%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAHA400089

Beneficial owner

Kuros Biosciences AG

Declared address

Kuros Biosciences AG, 8952 Schlieren

Conditional Obligation to issue new shares pursuant to a Combination Agreement entered with shareholders of Xpand Biotechnology BV on 18 December 2016: 1'365'000 shares of Kuros Biosciences Ltd have been issued and transferred at closing of the Combination Agreement and 370'000 shares of Kuros Biosciences Ltd have been issued and transferred after achievement of the first product milestone in September 2017. The remaining 370'000 shares of Kuros Biosciences Ltd to be issued at the achievement of certain product approval milestones.

Open shareholder profileOpen company profile

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open